NIFTY
-21.65  -0.20%
 10724.40
S&P BSE SENSEX
-67.27  -0.19%
 35808.95
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 15-Feb-2019
NSE
-18    -4.08%
Rs. 422.90
 
Days Low
Rs. 416.85
Days High
Rs. 441

Open Rs. 440.8
 
52 week Low
Rs. 375.4
52 week High
Rs.678.8
 
 
Bid :                 0.00 (0)
Offer :        423.30 (150)
BSE
Rs.423.30
-17.35    -3.94%
on 15-Feb-2019
BSE
-17.35    -3.94%
Rs. 423.30
 
Days Low
Rs. 416.45
Days High
Rs. 440.75

Open Rs. 440.75
 
52 week Low
Rs. 370.2
52 week High
Rs.679.3
 
 
Bid :                 0.00 (0)
Offer :        423.30 (150)
NSE
Rs.422.90
-18    -4.08%
 
 
Last Price (Rs.)  423.30 Value  327801139.00
Net Change (Rs.)  -17.35 Best Buy  0.00
Volume  772482 Best Sell  423.30
Prev.Close (Rs.)  440.65 Best Quantity  0
Open (Rs.)  440.80 Sell Quantity  150
High (Rs.)  441.00 52-Week High (Rs.)  678.80
Low (Rs.)  416.85 52-Week Low (Rs.)  375.40
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1015638.49
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Currents Investments447.60 400.10 735.60 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Cipla 540.40 435397 186.99 29.63 0.56
Divis Lab 1618.50 429661 251.75 49.41 0.62
Dr. Reddys Lab 2556.90 424601 749.84 74.87 0.78
Aurobindo Pharma 722.85 423523 188.62 23.36 0.35
Piramal Enterprises 2160.65 397646 1080.33 75.12 1.16
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2018Sep 2018Jun 2018
Net Sales22612.6022992.5026075.20
Operating Profit2023.705926.105375.80
PBDT689.90-7731.504007.90
Net Profit-386.80-9064.202593.90
More> 
 
Company News
2/13/2019 12:00:00 AM
Sun Pharma reports around 4-fold jump in Q3 consolidated net profit
2/13/2019 12:00:00 AM
Sun Pharma shines on reporting around 4-fold jump in Q3 consolidated n...
2/12/2019 12:00:00 AM
Outcome Of The Board Meeting Of The Company Held Today
More>
 
Ratios
   Earnings Per Share (Rs)-2.06 
   Book NAV/Share(Rs)82.40 
   PAT Margin (%)-6.22 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.40 
   EV/Core EBITDA(x)100.39 
   M Cap / Sales15.00 
   Net Sales Growth(%)3.12 
   PAT Growth(%)-2065.46 
   Total Debt/Equity(x)0.35 
   Current Ratio(x)0.56 
   Quick Ratio(x)0.39 
   Total Debt/Mcap(x)0.06 
More>